Director, Medical and Clinical Operations

Chris Ockenhouse provides scientific and clinical guidance to translational project teams in charge of early clinical development, working closely with MVI staff, partners, and academic investigators. He also provides medical and scientific expertise on clinical malaria, clinical immunology, and trial design. He serves on MVI’s Portfolio Management Committee and on the MVI Leadership Team.

Chris has 25 years of experience leading R&D programs focused on discovery, process development, manufacture, and early clinical testing of multiple vaccine candidates against Plasmodium falciparum and P. vivax malaria. Prior to joining MVI, Chris was Director of the Malaria Vaccine Program at the Walter Reed Army Institute of Research (WRAIR), where he directed the formation and operations of the first joint US Army-Navy Military Malaria Vaccine Program dedicated to developing malaria vaccines within the Department of Defense. He recently retired from active duty as a Colonel in the US Army.

Chris received his medical degree from the Medical College of Pennsylvania in Philadelphia, a PhD in immunology & parasitology from the Sackler Institute for Biomedical Sciences at New York University, an MS in parasitology from the Tulane University School of Tropical Medicine and Hygiene in New Orleans, and a BS (honors) from Wheaton College. Chris has also published more than 100 articles in scientific and medical literature.